BPC
MJN

Banque Pictet & Cie’s Mead Johnson Nutrition Company MJN Stock Holding History

Banque Pictet & Cie’s Portfolio MJN Stock Details MJN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-5,000
Closed -$354K – 369
2016
Q4 		$354K Buy
+5,000
New +$373K 0.01% 291

Other funds holding MJN

PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM
FNBOO
First National Bank of Omaha Omaha, Nebraska $3.55B AUM 27.24% 1-Year Est. Return
LFAS
Level Four Advisory Services Dallas, Texas $3.54B AUM 37.12% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
CPIG
Chicago Partners Investment Group Chicago, Illinois $5B AUM 26.84% 1-Year Est. Return
WEC
Winslow Evans & Crocker Boston, Massachusetts $528M AUM 30.99% 1-Year Est. Return

Banque Pictet & Cie's MJN Position: Q2 2017 in Review

Banque Pictet & Cie sold out of Mead Johnson Nutrition Company (MJN) in Q2 2017, closing a stake of 63,931 shares — an estimated $5.7M sold.

Banque Pictet & Cie first reported a position in MJN in Q4 2013 and held it in 14 quarters. The position peaked at $6.93M in Q1 2016. 7 funds tracked by Wall St. Rank hold MJN as of Q2 2017.

  • Banque Pictet & Cie reported no remaining Mead Johnson Nutrition Company position as of Q2 2017 after selling out during the quarter.
  • Banque Pictet & Cie sold 63,931 Mead Johnson Nutrition Company shares in Q2 2017, an estimated $5.7M.
  • Banque Pictet & Cie first reported a position in Mead Johnson Nutrition Company in Q4 2013 and held it in 14 quarters.
  • Banque Pictet & Cie's Mead Johnson Nutrition Company position peaked at $6.93M in Q1 2016.
  • 7 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q2 2017.

Based on Banque Pictet & Cie's 13F filing for Q2 2017, filed 9 Aug 2017.